Table 3.
Methylation Δbeta values (methylation frequencies) between various tumor characteristics.
| Gene | CpG site | INRG (M/L) | 1p-dela | MNAa | 11q-dela | 17q-gaina | >18 m |
|---|---|---|---|---|---|---|---|
| SCNN1A | cg18738906 | 0.33*** | 0.15 | 0.21** | 0.25*** | 0.34*** | 0.15* |
| cg26215727 | 0.15** | 0.04 | 0.13* | 0.17** | 0.20*** | 0.09 | |
| PRKCDBP | cg05628549 | 0.09 | -0.06 | 0.12 | 0.08 | 0.09 | -0.10 |
| cg16245261 | 0.17* | 0.00 | 0.27*** | 0.15 | 0.19* | 0.01 | |
| cg18392783 | 0.12 | -0.06 | 0.18** | 0.10 | 0.12 | -0.02 | |
| cg18959478 | 0.12 | -0.06 | 0.16* | 0.10 | 0.11 | -0.04 | |
| KRT19 | cg11462865 | 0.14 | -0.01 | 0.19* | 0.10 | 0.12 | 0.22** |
| cg16585619 | 0.01 | -0.05* | 0.07*** | 0.04* | 0.03 | 0.01 | |
| TGFBI | cg00386408 | 0.05 | -0.04 | 0.11 | 0.10 | 0.07 | 0.14* |
| cg21034676 | 0.04 | -0.04 | 0.13 | 0.06 | 0.05 | 0.12 | |
| POU2F2 | cg21608489 | -0.08 | -0.05 | -0.08 | -0.01 | -0.04 | -0.08 |
| cg22054191 | 0.03 | -0.03 | -0.01 | 0.04 | 0.02 | 0.04 | |
| DUSP23 | cg10663017 | 0.06 | -0.10 | 0.27*** | 0.21*** | 0.16** | 0.07 |
| cg11104347 | 0.05 | -0.13* | 0.29*** | 0.16** | 0.13** | 0.08 | |
| DHRS3 | cg01346152 | -0.13 | -0.03 | -0.20** | -0.03 | -0.08 | -0.10 |
| cg09229231 | 0.004* | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| COL1A2 | cg18511007 | 0.07 | 0.00 | 0.05 | 0.07 | -0.01 | 0.18** |
| cg25300386 | 0.02 | -0.04 | -0.02 | 0.02 | -0.09 | 0.15* |
M, metastatic; L, localized; 1p-del, 1p-deletion; MNA, MYCN amplification; 11q-del, 11q-deletion; m, months; apresence of chromosomal aberration tested against absence; *p ≤ 0.05; **p < 0.01; ***p < 0.001